Suppr超能文献

估算实现《2006 - 2015年世界卫生组织 - 联合国儿童基金会全球免疫远景与战略》的成本。

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

作者信息

Wolfson Lara J, Gasse François, Lee-Martin Shook-Pui, Lydon Patrick, Magan Ahmed, Tibouti Abdelmajid, Johns Benjamin, Hutubessy Raymond, Salama Peter, Okwo-Bele Jean-Marie

机构信息

World Health Organization, Geneva, Switzerland.

出版信息

Bull World Health Organ. 2008 Jan;86(1):27-39. doi: 10.2471/blt.07.045096.

Abstract

OBJECTIVE

To estimate the cost of scaling up childhood immunization services required to reach the WHO-UNICEF Global Immunization Vision and Strategy (GIVS) goal of reducing mortality due to vaccine-preventable diseases by two-thirds by 2015.

METHODS

A model was developed to estimate the total cost of reaching GIVS goals by 2015 in 117 low- and lower-middle- income countries. Current spending was estimated by analysing data from country planning documents, and scale-up costs were estimated using a bottom-up, ingredients-based approach. Financial costs were estimated by country and year for reaching 90% coverage with all existing vaccines; introducing a discrete set of new vaccines (rotavirus, conjugate pneumococcal, conjugate meningococcal A and Japanese encephalitis); and conducting immunization campaigns to protect at-risk populations against polio, tetanus, measles, yellow fever and meningococcal meningitis.

FINDINGS

The 72 poorest countries of the world spent US$ 2.5 (range: US$ 1.8-4.2) billion on immunization in 2005, an increase from US$ 1.1 (range: US$ 0.9-1.6) billion in 2000. By 2015 annual immunization costs will on average increase to about US$ 4.0 (range US$ 2.9-6.7) billion. Total immunization costs for 2006-2015 are estimated at US$ 35 (range US$ 13-40) billion; of this, US$ 16.2 billion are incremental costs, comprised of US$ 5.6 billion for system scale-up and US$ 8.7 billion for vaccines; US$ 19.3 billion is required to maintain immunization programmes at 2005 levels. In all 117 low- and lower-middle-income countries, total costs for 2006-2015 are estimated at US$ 76 (range: US$ 23-110) billion, with US$ 49 billion for maintaining current systems and $27 billion for scaling-up.

CONCLUSION

In the 72 poorest countries, US$ 11-15 billion (30%-40%) of the overall resource needs are unmet if the GIVS goals are to be reached. The methods developed in this paper are approximate estimates with limitations, but provide a roadmap of financing gaps that need to be filled to scale up immunization by 2015.

摘要

目标

评估扩大儿童免疫服务规模所需的成本,以实现世界卫生组织-联合国儿童基金会全球免疫远景与战略(GIVS)提出的到2015年将疫苗可预防疾病导致的死亡率降低三分之二的目标。

方法

建立一个模型来估算117个低收入和中低收入国家到2015年实现GIVS目标的总成本。通过分析各国规划文件中的数据估算当前支出,并采用自下而上的基于构成要素的方法估算扩大规模的成本。按国家和年份估算实现所有现有疫苗90%覆盖率、引入一组特定新疫苗(轮状病毒、结合型肺炎球菌、结合型A群脑膜炎球菌和日本脑炎疫苗)以及开展免疫运动以保护高危人群免受脊髓灰质炎、破伤风、麻疹、黄热病和脑膜炎球菌性脑膜炎侵害的财务成本。

结果

2005年世界上72个最贫穷国家的免疫支出为25亿美元(范围:18亿-42亿美元),高于2000年的11亿美元(范围:9亿-16亿美元)。到2015年,年度免疫成本平均将增至约40亿美元(范围:29亿-67亿美元)。2006 - 2015年的免疫总成本估计为350亿美元(范围:130亿-至400亿美元);其中,162亿美元为增量成本,包括56亿美元用于系统扩大规模和87亿美元用于疫苗;需要193亿美元将免疫计划维持在2005年的水平。在所有117个低收入和中低收入国家,2006 - 2015年的总成本估计为760亿美元(范围:230亿-1100亿美元),其中490亿美元用于维持现有系统,270亿美元用于扩大规模。

结论

在72个最贫穷国家,如果要实现GIVS目标,总体资源需求中有110亿-150亿美元(30%-40%)未得到满足。本文所采用的方法是有局限性的近似估算,但提供了到2015年扩大免疫规模所需填补的资金缺口路线图。

相似文献

1
Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.
Bull World Health Organ. 2008 Jan;86(1):27-39. doi: 10.2471/blt.07.045096.
2
Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Vaccine. 2005 Aug 31;23(37):4610-8. doi: 10.1016/j.vaccine.2005.04.044.
3
Costs of vaccine programs across 94 low- and middle-income countries.
Vaccine. 2015 May 7;33 Suppl 1:A99-108. doi: 10.1016/j.vaccine.2014.12.037.
5
Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030.
Value Health. 2021 Jan;24(1):70-77. doi: 10.1016/j.jval.2020.07.010. Epub 2020 Oct 31.
10
Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.
Bull World Health Organ. 2017 Sep 1;95(9):629-638. doi: 10.2471/BLT.16.178475. Epub 2017 Jun 27.

引用本文的文献

2
Unintended pregnancies: a comprehensive cost-benefit analysis of family planning investment in Pakistan.
Front Public Health. 2025 May 19;13:1563721. doi: 10.3389/fpubh.2025.1563721. eCollection 2025.
3
Cost-effectiveness analysis of alternative infant and neonatal rotavirus vaccination schedules in Malawi.
PLOS Glob Public Health. 2025 Apr 10;5(4):e0004341. doi: 10.1371/journal.pgph.0004341. eCollection 2025.
6
Age-appropriate vaccination and associated factors among children aged 12-35 months in Ethiopia: A multi-level analysis.
PLoS One. 2024 Oct 10;19(10):e0305801. doi: 10.1371/journal.pone.0305801. eCollection 2024.
10
Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk.
Lancet Reg Health Southeast Asia. 2023 Feb 21;11:100158. doi: 10.1016/j.lansea.2023.100158. eCollection 2023 Apr.

本文引用的文献

2
Economic evaluation of measles catch-up and follow-up campaigns in Afghanistan in 2002 and 2003.
Disasters. 2006 Jun;30(2):256-69. doi: 10.1111/j.0361-3666.2006.00318.x.
3
A new global immunisation vision and strategy.
Lancet. 2006 May 6;367(9521):1464-6. doi: 10.1016/S0140-6736(06)68625-X.
5
Financial challenges of immunization: a look at GAVI.
Bull World Health Organ. 2004 Sep;82(9):697-702.
8
Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
Vaccine. 2004 Sep 3;22(25-26):3419-26. doi: 10.1016/j.vaccine.2004.02.042.
9
Cost-effectiveness of three different vaccination strategies against measles in Zambian children.
Vaccine. 2004 Jan 2;22(3-4):475-84. doi: 10.1016/j.vaccine.2003.07.007.
10
Introducing GAVI and the Global Fund for Children's Vaccines.
Vaccine. 2000 Oct 15;19(4-5):385-6. doi: 10.1016/s0264-410x(00)00196-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验